Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KNSA | Kiniksa Pharmaceuticals, Ltd. | Jun 5, 2024 | 4 | $0 | 4 | Jun 7, 2024 | Director |
KURA | Kura Oncology, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Jun 29, 2023 | 2 | $0 | 4 | Jul 3, 2023 | Director |
KURA | Kura Oncology, Inc. | Jun 16, 2023 | 1 | $575K | 4 | Jun 21, 2023 | Director |
BGNE | BeiGene, Ltd. | Jun 15, 2023 | 2 | $0 | 4 | Jun 20, 2023 | Director |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
KURA | Kura Oncology, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Jun 29, 2022 | 2 | $0 | 4 | Jun 30, 2022 | Director |
BGNE | BeiGene, Ltd. | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
KURA | Kura Oncology, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Jun 29, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |
KURA | Kura Oncology, Inc. | Jun 22, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |
BGNE | BeiGene, Ltd. | Jun 16, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |